Monographie - Insulin lyspro

Poslední aktualizace :
14/12/2024

Insulin lyspro

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Humalog

Airija, Argentina, Austrija, Belgija, Čilė, Danija, Didžioji Britanija, Ekvadoras, Graikija, Islandija, Ispanija, Italija, Japonija, Jungtinės Amerikos Valstijos, Kanada, Kolumbija, Kroatija, Lenkija, Liuksemburgas, Malaizija, Marokas, Meksikas, Norvegija, Olandija, Pietų Afrikos Respublika, Portugalija, Prancūzija, Rumunija, Saudo Arabija, Slovėnija, Suomija, Švedija, Šveicarija, Turkija, Venesuela, Vengrija, Vokietija

Bibliografija : Insulin lyspro

	tipas	leidinys
2269	Žurnalas	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3149	Žurnalas	DeFelippis MR, Bell MA, Heyob JA, Storms SM. In Vitro Stability of Insulin Lispro in Continuous Subcutaneous Insulin Infusion. Diabetes Tech and Ther 2006 ; 8, 3: 358-368.
3249	Žurnalas	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
4433	Žurnalas	Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K. Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications Clin Ther 2020 ; 42, 3: 475-485.
4650	Laboratorija	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021

Mentions Légales